System Transmission

Top Signal

100#1 JOB

Activity

2192Ripe

+952 today

System

Livenow

Terminal Asset View

stockNASDAQ

VYNE

$0.59+0.66%

VYNE Therapeutics Inc. - Common Stock

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

83Ripe

Live Analysis Active

Synchronizing Data Stream

Establishing multi-vendor link for VYNE

Pipeline Initializing...

System Progress0%

Low Latency Link

Encrypted Port

Company Mission

It creates and sells drugs to treat skin diseases such as eczema and psoriasis. Doctors and patients use these treatments to manage symptoms and improve quality of life. The company makes money by selling its products to healthcare systems and entering into licensing deals with other firms.

VYN

Industry Context

This company operates in the biotech and pharmaceuticals industry, focusing on developing treatments for dermatological conditions. It competes with larger firms by targeting niche markets with high unmet medical needs. The industry is driven by innovation, regulatory approvals, and partnerships. Success often depends on clinical trial outcomes and market adoption.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

93Matrix

Market Momentum

48.1— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

0.66%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-0

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing VYNE across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:55 AM UTC

As-of As of 2026-03-16T02:40:17.157Z UTC (~15m delay).

Develops innovative skin treatments for conditions like eczema and psoriasis, generating revenue through drug sales and partnerships with healthcare providers.

Technical Pattern is forming near , suggesting bullish momentum as the asset consolidates above key support. Watch for a breakout above $0.59.

Volume spiked 3x at $2, indicating buyer interest because it coincided with positive clinical trial news. Monitor if volume stays elevated above average.

Industry Trend is driving strength, with price holding above $0.59, signaling resilience in the biotech sector. Watch for sector recovery and FDA approvals.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...